NCT04218513

Drug-drug Interaction Study Between Edaravone and 2-Aminoethanesulfonic Acid in Compound Edaravone Injection

An Experiment to Evaluate the Drug-drug Interaction of Formula Edaravone and Formula 2-Aminoethanesulfonic Acid in Compound Edaravone Injection

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Nanjing Yoko Biomedical Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

An experiment to evaluate the drug-drug interaction of formula edaravone and formula 2-aminoethanesulfonic acid in compound edaravone injection.

Conditions

• Drug-drug Interaction

Interventions

Type	Name	Description
DRUG	Compound Edaravone Injection	30 min intravenous infusion
DRUG	Edaravone Injection	30 min intravenous infusion
DRUG	2-Aminoethanesulfonic Acid Injection	30 min intravenous infusion

Timeline

• Start date: 2019-05-10
• Primary completion: 2019-05-31
• Completion: 2019-05-31
• First posted: 2020-01-06
• Last updated: 2021-03-22

Locations

1 site across 1 country: China